A survey of efficacy of zolpidem in patients with brain injury including SPECT brain scans in selected patients - zolpidem in brain damage
- Conditions
- Brain damage of any original cause, such as strokes, trauma, birth injury, post-viral infection.MedDRA version: 9.1Level: LLTClassification code 10056389Term: Brain damage
- Registration Number
- EUCTR2007-000083-24-GB
- Lead Sponsor
- Regen Therapeutics PLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria
Male or female patients of 12 or more years who have stable deficits of motor or cognitive function due to brain damage of any cause that was sustained at least 4 months beforehand.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusion Criteria
1. Objection to the study by patients or patients’ families or medical practitioners.
2. Patients who are known not to tolerate zolpidem
3. Patients less than 12 years old
4. Pregnant women
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method